Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 3
2008 pubmed 21 citations

Up-regulation of high voltage-activated Ca(2+) channels in GC somatotropes after long-term exposure to ghrelin and growth hormone releasing peptide-6.

Dominguez. Belisario B; Avila. Traudy T; Flores-Hernandez. Jorge J; Lopez-Lopez. Gustavo G; Martinez-Rodriguez. Herminia H; Felix. Ricardo R; Monjaraz. Eduardo E

Key Findings

  • Chronic GHRP‑6 or ghrelin exposure selectively increases high‑voltage‑activated (HVA) calcium currents in GH‑producing cells.
  • The increase is due to more functional L‑type CaV1.3 channels in the cell membrane, not changes in channel kinetics.
  • Blocking the GHS‑R receptor prevents the up‑regulation, confirming the effect is receptor‑mediated.
  • Medium‑voltage‑activated (MVA) calcium currents show only a modest rise.

Practical Outcomes

  • For biohackers, the data suggest that regular (multi‑day) GHRP‑6 dosing might boost the cell’s capacity to release growth hormone by increasing calcium channel numbers, not just cause short‑term spikes. However, the work is in rat tumor cells, so human effects, optimal dosing, and safety are still unknown and need clinical confirmation.

Summary

The study shows that giving cells a ghrelin‑like peptide (GHRP‑6) for several days makes them produce more of a specific calcium channel (L‑type) that helps release growth hormone. This effect was seen in rat pituitary tumor cells and was blocked when the receptor was blocked, indicating the peptide itself caused the change.

Abstract

Activation of the growth hormone (GH)-secretagogue receptor (GHS-R) by synthetic GH-releasing peptides (GHRP) or its endogenous ligand (ghrelin) stimulates GH release. Though much is known about the signal transduction underlying short-term regulation, there is far less information on mechanisms that produce long-term effects. In the current report, using whole-cell patch-clamp recordings, we assessed the long-term actions of such regulatory factors on voltage-activated Ca(2+) currents in GH-secreting cells derived from a rat pituitary tumour (GC cell line). After 96 h in culture, all recorded GC somatotropes exhibited two main Ca(2+) currents: a medium voltage-activated (MVA; T/R-type) and a high voltage-activated (HVA; mostly dihydropyridine-sensitive L-type) current. Interestingly, L- and non-L-type channels were differentially up-regulated by GHRP-6 and ghrelin. Chronic treatment with the GHS induced a significant selective increase on Ba(2+) current through HVA Ca(2+) channels, and caused only a modest increase of currents through MVA channels. Consistent with this, in presence of D-(Lys(3))-GHRP-6, a specific antagonist of the GHS-R, the increase in HVA Ca(2+) channel activity after chronic treatment with the GHS was abolished. The stimulatory effect on HVA current density evoked by the secretagogues was accompanied by an augment in maximal conductance with no apparent changes in the kinetics and the voltage dependence of the Ca(2+) currents, suggesting an increase in the number of functional channels in the cell membrane. Lastly, in consistency with the functional data, quantitative real-time RT-PCR revealed that the expression level of transcripts encoding for the Ca(V)1.3 pore-forming subunit of the L-type channels was significantly increased after chronic treatment of the GC cells with ghrelin.

Study Information

Provider

pubmed

Year

2008

Date

2008-02-08T00:00:00.000Z

DOI

10.1007/s10571-007-9234-1

Citations

21

References

61